Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Managed Care (Langhorne, Pa.)|November 3, 2015
Cost Differences Between Open and Minimally Invasive SurgeryKathryn Fitch, Tyler Engel, Andrew BochnerJournal of Pharmacological and Toxicological Methods|May 1, 2017
Computational modeling for cardiac safety pharmacology analysis: Contribution of fibroblastsXin Gao, Tyler Engel, Brian E Carlson, et al.American Health & Drug Benefits|August 11, 2017
The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial PayersKathryn Fitch, J Michael Woolley, Tyler Engel, et al.American Health & Drug Benefits|July 27, 2019
Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service PopulationKathryn Fitch, Xiaoyun Pan, Jocelyn Lau, et al.Current Medical Research and Opinion|June 23, 2017
Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysisKathryn Fitch, Tyler Engel, Stephen Sander, et al.American Health & Drug Benefits|November 12, 2015
Longitudinal Commercial Claims-Based Cost Analysis of Diabetic Retinopathy Screening PatternsKathryn Fitch, Thomas Weisman, Tyler Engel, et al.Clinicoeconomics and Outcomes Research : CEOR|December 28, 2018
The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settingsKathryn Fitch, Jocelyn Lau, Tyler Engel, et al.Journal of Managed Care & Specialty Pharmacy|May 5, 2025
The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation studyAndrew S Aguilar, Tyler Engel, Wesley Furnback, et al.Pageof 1